Last reviewed · How we verify
NCT05289895
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques
trial testing No intervention in Proteomics in 220 participants. Status unknown.
1 March 2023
Quick facts
| Lead sponsor | The Affiliated Hospital of Qingdao University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 220 |
| Start date | 1 April 2022 |
| Primary completion | 1 March 2023 |
| Estimated completion | 30 December 2024 |
Drugs / interventions tested
- No intervention
Conditions studied
- Proteomics — all drugs for Proteomics →
- Pancreatic Cancer — all drugs for Pancreatic Cancer →
- Prognostic Biomarkers — all drugs for Prognostic Biomarkers →
Sponsor
The Affiliated Hospital of Qingdao University
Who can join
Eligibility, any sex, with Proteomics or Pancreatic Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sequence I (Retrospective study: proteomic analysis of pathological specimens and information collection of previous patients with pancreatic cancer) Sequence 2 (Non-interventional prospective study, sample and information collection in patients with pancreatic cancer) Sequence 3 (Non-intervention study, healthy subjects sample and information collection)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05289895
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention
Trials testing the same drug.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
- NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
Other recruiting trials for Proteomics
Currently open trials in the same condition.
- NCT07017374 — Proteomic Analysis of Serum Samples After Cardiac Arrest: a TTM-trial Substudy · active not recruiting
- NCT06904677 — Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer · recruiting
- NCT06097065 — Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform. · recruiting
- NCT05307367 — Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms · NA · recruiting
- NCT04514744 — Dynamic Proteomics and Integrated Rates of Muscle Protein Synthesis During an Acute Period of Loading and Unloading · NA · active not recruiting
Other The Affiliated Hospital of Qingdao University trials
Trials by the same sponsor.
- NCT07485920 — A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedani · Phase 4 · not yet recruiting
- NCT07465861 — Bed Rest Duration and Outcomes in Endoscopic Skull Base Reconstruction · NA · not yet recruiting
- NCT07453771 — Safety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With Asthma · NA · not yet recruiting
- NCT07404709 — Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Ste · Phase 1, PHASE2 · not yet recruiting
- NCT07167342 — The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05289895 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Affiliated Hospital of Qingdao University
- Last refreshed: 22 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05289895.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing